Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study

Vickers, RJ, Tillotson, GS, Nathan, R et al. (41 more authors) (2017) Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study. The Lancet Infectious Diseases, 17 (7). pp. 735-744. ISSN 1473-3099

Abstract

Metadata

Authors/Creators:
  • Vickers, RJ
  • Tillotson, GS
  • Nathan, R
  • Hazan, S
  • Pullman, J
  • Lucasti, C
  • Deck, K
  • Yacyshyn, B
  • Maliakkal, B
  • Pesant, Y
  • Tejura, B
  • Roblin, D
  • Gerding, DN
  • Wilcox, MH https://orcid.org/0000-0002-4565-2868
  • Bhan, A
  • Campbell, W
  • Chopra, T
  • Deck, K
  • Golan, Y
  • Gordon, I
  • Kamepalli, R
  • Khanna, S
  • Lee, C
  • Lucasti, C
  • Maliakkal, B
  • Minang, I
  • Mullane, K
  • Nathan, R
  • Oughton, M
  • Pesant, Y
  • Phillips, J
  • Pullman, J
  • Riska, P
  • Schrock, C
  • Siegel, J
  • Steinberg, A
  • Talan, D
  • Tamang, S
  • Tan, M
  • Weiss, K
  • Wang, C
  • Yacyshyn, B
  • Young, J-A
  • Zenilman, J
Copyright, Publisher and Additional Information: © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Dates:
  • Published: July 2017
  • Accepted: 2 March 2017
  • Published (online): 28 April 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Molecular Gastroenterology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 08 May 2017 09:09
Last Modified: 24 Jul 2017 09:05
Published Version: https://doi.org/10.1016/S1473-3099(17)30235-9
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/S1473-3099(17)30235-9

Share / Export

Statistics